Automated Method Developed for Near-IR Fluorescent Labeling of Monoclonal Antibodies Under cGMP Standards

Researchers have introduced an automated method for fluorescently labeling monoclonal antibodies under current good manufacturing practices (cGMP), marking a significant advancement in molecular imaging and targeted therapies. This development simplifies the production of near-infrared (near-IR) fluorescently labeled antibodies, which are essential for achieving safe and high-resolution optical imaging in clinical applications.

The new approach focuses on streamlining the labeling process while adhering to cGMP standards, ensuring that the resulting antibodies meet regulatory requirements for clinical use. Near-IR fluorescent labeling enhances the ability to visualize biological processes with precision, making it a valuable tool in diagnostics and treatment monitoring. The automation of this process represents a step forward in improving efficiency and scalability in antibody production for medical imaging purposes.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 7, 2026

Author

GOAI